MDHCX quote
5.35up +0.03 +0.56%
Previous Close5.32CategoryHealth
Net Assets133.16 MilDividend Yield0.00%
Morningstar ratings:Minimum Initial Purchase1,000
RiskAverage1 Year Return33.33%
RatingRating: 3 out of 53 Year Return2.20%
ReturnAverage5 Year Return5.38%
Cumulative growth of a $10,000 investment
10k growth chart
20042005200620072008YTD
Growth10.24%25.89%26.36%50.25%10.74%26.99%
Value$11,024$12,589$12,636$15,025$11,074$12,699
Last NAV update 8:00 PM ET   Financial data in U.S. dollars

Your latest quotes:  CNP, VITA, MSFT, DHI, AXTI, MDHCX

Overview
The investment seeks long-term capital appreciation. The fund normally invests 80% of assets in securities of healthcare companies. It seeks to invest in companies that it believes it has good prospects for earnings growth. The fund may invest without limit in foreign securities and in depositary receipts. It may also invest in convertible securities and rights. These range from very large corporations to small, developmental stage companies. The fund is nondiversified.
More information for MDHCX
Fees and expenses
Front load5.25%
Deferred load0.00%
Expense Ratio1.62%
Top holdings for MDHCX
Company Name% Net Assets
Celgene Corporation8.34%
Blackrock Liquidity Series, Llc Money Ma7.11%
Hlth Corporation6.67%
Gilead Sciences, Inc.6.49%
Genzyme Corporation4.84%
More top holdings for MDHCX
Additional Fund Information
Inception date10/21/1994
ManagerRobert C. Hodgson
Manager start date12/31/1997
advertisement
Market update 5:37pm ET

7 things to ask before buying a stock

Putting your money in the market can leave you open to some nasty surprises. Avoid them by doing the right research.

More market news
advertisement


Page generated 8:37 PM Eastern Time